Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.

<h4>Background</h4>Uganda recently adopted artemether-lumefantrine (AL) as the recommended first-line treatment for uncomplicated malaria. However, AL has several limitations, including a twice-daily dosing regimen, recommendation for administration with fatty food, and a high risk of reinfection so...

Повний опис

Бібліографічні деталі

Автори:	Adoke Yeka, Grant Dorsey, Moses R Kamya, Ambrose Talisuna, Myers Lugemwa, John Bosco Rwakimari, Sarah G Staedke, Philip J Rosenthal, Fred Wabwire-Mangen, Hasifa Bukirwa
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Public Library of Science (PLoS) 2008-06-01
Серія:	PLoS ONE
Онлайн доступ:	https://escholarship.org/uc/item/0dh8831z
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!